Renascience Inc.TSE 4889

株式会社レナサイエンス · Pharmaceutical · FY ends Mar

Share price at FY-end
¥1,047
FY ending Mar 2026 (approx.)
Market cap at FY-end
¥14.4B
Dividend per share
—
Avg. director pay
¥14.0M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 特定有価証券信託受託者 株式会社SMBC信託銀行 4,360,600 31.65% ¥4.6B —
2 宮田 敏男 1,470,700 10.68% ¥1.5B —
3 Ueda Yagi Tanshi Co., Ltd.
Asset-management company of 八木 徹
300,000 2.18% ¥314M —
4 BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE 276,100 2.00% ¥289M —
5 BofAS Inc Segregation Account 263,400 1.91% ¥276M —
6 楽天証券株式会社共有口 189,800 1.38% ¥199M —
7 林田 広明 173,000 1.26% ¥181M —
8 第一リアルター株式会社 156,900 1.14% ¥164M —
9 株式会社SBI証券 150,621 1.09% ¥158M —
10 飯田 晋一 64,300 0.47% ¥67.3M —

Officers' holdings and pay

NameTitleSharesValuePay
宮田 敏男 Chairman of the Board 2,736,700 ¥2.9B —
鎌田 光明 Executive Vice President & Director — — —
能城 弘昭 Director — — —
高山 和江 Director — — —
伊藤 彰彦 Director — — —
北浦 聡 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥1,047 ¥-23.39 — — 13,776,900
FY ending Mar 2025 ¥1,047 ¥8.92 117.4x — 12,711,700
FY ending Mar 2024 ¥1,047 ¥-20.32 — — 12,711,700
FY ending Mar 2023 — ¥-26.42 — — 12,711,700
Source: annual securities reports on EDINET. Values are estimates. Methodology